US FDA Approves Sun Pharma’s New BLU-U® Blue Light Therapy Device for Actinic Keratosis
Sun Pharma has received US FDA approval for its next-generation BLU-U® Blue Light Photodynamic Therapy (PDT) device, Model 4170E. This device is designed to treat actinic keratosis (AK), a condition caused by prolonged sun exposure that can lead to skin…








